UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 10-Q

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended November 30, 2018

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 333-173456

Jubilant Flame International, LTD

(Exact name of registrant as specified in its charter)

Nevada

(State or other jurisdiction of incorporation or organization)

10F., YUNFENG BUILDING, NO. 478 WUZHONG RD, Shanghai, China 201103

(Address of principal executive offices, including zip code.)

+ 86 21 64748888

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES x NO ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files) YES x NO ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a small reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “small reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	¨	Accelerated filer	¨
Non-accelerated filer	¨	Smaller reporting company	x
Emerging growth company	¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ¨ No x

As of January 10, 2019, there are 18,485,708 shares of common stock outstanding.

All references in this Report on Form 10-Q to the terms “we”, “our”, “us”, the “Company” and the “Registrant” refer to Jubilant Flame International Ltd unless the context indicates another meaning.

JUBILANT FLAME INTERNATIONAL LTD

TABLE OF CONTENTS

		Page
PART I – FINANCIAL INFORMATION
Item 1.	Financial Statements	F-1
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	3
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	6
Item 4.	Controls and Procedures	6
PART II – OTHER INFORMATION
Item 1.	Legal Proceedings	7
Item 1A.	Risk Factors	7
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	7
Item 3.	Defaults Upon Senior Securities	7
Item 4.	Mine Safety Disclosures	7
Item 5.	Other Information	7
Item 6.	Exhibits	8
SIGNATURES		9

2

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

JUBILANT FLAME INTERNATIONAL, LTD.

FOR THE THREE AND NINE MONTH PERIODS ENDED NOVEMBER 30, 2018 AND 2017

Index to Unaudited Financial Statements

Contents	Page
Balance Sheets November 30, 2018 and February 28, 2018 (Unaudited)	F-2
Statements of Operations for the Three and nine-Month Periods Ended November 30, 2018 and 2017 (Unaudited)	F-3
Statements of Changes in Stockholders’ Deficit for the Nine Months Ended November 30, 2018 (Unaudited)	F-4
Statements of Cash Flows for the Nine-Month Periods Ended November 30, 2018 and 2017 (Unaudited)	F-5
Notes to the Financial Statements (Unaudited)	F-6

F-1

JUBILANT FLAME INTERNATIONAL, LTD

Balance Sheets

(Unaudited)

	November 30,			February 28,
	2018			2018
ASSETS
Current assets
Cash	$	15,881		$	8,036
Account receivable		2,964			594
Inventory		9,813			5,933
Prepaid expenses		12,000			7,500
Total current assets		40,658			22,063
Other assets
Website net of $25,000 and $21,527 of amortization, respectively		-			3,473
Total other assets		-			3,473
Total Assets	$	40,658		$	25,536
LIABILITIES & STOCKHOLDERS' DEFICIT
Current liabilities
Accounts payable and accrued liabilities	$	3,169		$	-
Due to related party		41,835			12,842
Accrued officer compensation		535,500			460,125
Loan payable - related parties		438,149			390,828
Total current liabilities		1,018,653			863,795
Total Liabilities		1,018,653			863,795
Stockholders' Deficit
Common stock, $0.001 par value per share
75,000,000 shares authorized; 18,485,708 and
18,410,708 shares issued and outstanding, respectively		18,486			18,411
Additional paid in capital		2,416,545			2,259,120
Accumulated deficit		(3,413,026	)		(3,115,790	)
Total Stockholders' Deficit		(977,995	)		(838,259	)
Total Liabilities and Stockholders' Deficit	$	40,658		$	25,536

The accompanying notes are an integral part of these financial statements.

F-2

JUBILANT FLAME INTERNATIONAL, LTD

Statements of Operations

(Unaudited)

	For the three months ended						For the nine months ended
	November 30,						November 30,
	2018			2017			2018			2017
Sales of goods	$	24,099		$	-		$	38,190			-
Total sales		24,099			-			38,190			-
Costs and Operating Expenses:
Cost of goods sold		16,856			-			24,342			-
Operating, selling, general and administrative		101,458			171,429		$	311,084		$	526,351
Total operating expenses		118,314			171,429			335,426			526,351
Loss from operations		(94,215	)		(171,429	)		(297,236	)		(526,351	)
Other income (expense):
Change and gain in derivatives liability		-			-			-			(3,120	)
Debt discount amortization expense		-			-			-			(4,238	)
Interest expense		-			-			-			(320	)
Other income (expense) net		-			-			-			(7,678	)
Income (loss) from continuing operations before provision for income taxes		(94,215	)		(171,429	)		(297,236	)		(534,028	)
Provision for income tax:		-			-			-			-
Net income (loss)	$	(94,215	)	$	(171,429	)	$	(297,236	)	$	(534,028	)
Net loss per share
(Basic and fully diluted)	$	(0.01	)	$	(0.01	)	$	(0.02	)	$	(0.03	)
Weighted average number of common shares outstanding		18,460,983			18,360,983			18,435,890			18,233,937

 

The accompanying notes are an integral part of the audited financial statements.

 

F-3

JUBILANT FLAME INTERNATIONAL, LTD

Statements of Changes in Stockholders' Deficit

(Unaudited)

	Common Stock				Additional paid in		Accumulated			Total Stockholders’
	Shares		Amount		capital		deficit			Deficit
Balances at February 28, 2018		18,410,708	$	18,411	$	2,259,120	$	(3,115,790	)	$	(838,259	)
Shares issued for stock compensation		75,000		75		157,425					157,500
Net loss for the period								(297,236	)		(297,236	)
Balances at November 30, 2018		18,485,708	$	18,486	$	2,416,545	$	(3,413,026	)	$	(977,995	)

The accompanying notes are an integral part of these financial statements

F-4

JUBILANT FLAME INTERNATIONAL, LTD

Statements of Cash Flows

(Unaudited)

	For the nine months ended November 30,
	2018			2017
Cash Flows from Operating Activities:
Net loss	$	(297,236	)	$	(534,028	)
Adjustments to reconcile net (loss) to net cash (used in) operating activities
Website amortization		3,473			6,250
Debt discount amortization		-			4,238
Change in derivatives liability		-			4,362
Derivatives extinguishment gain		-			(1,242	)
Stock compensation		157,500			265,125
Changes in Current Assets and Liabilities:
Account receivable		(2,370	)		-
Inventory		(3,880	)		-
Prepaid expense		(4,500	)		(2,812	)
Accounts payable		3,170			(575	)
Due to related party		28,993
Accrued officer's compensation		75,375			125,625
Net cash used in operating activities		(39,475	)		(133,057	)
Cash Flows from Financing Activities:
Net proceeds from related party loans		47,321			137,598
Debt payoff		-			(800	)
Net cash provided by financing activities		47,321			136,798
Net Increase In Cash		7,846			3,741
Cash at Beginning of Period		8,036			3,653
Cash at End of Period	$	15,882		$	7,394
Schedule of Non-Cash Investing and Financing Activities
Convertible note reduction associated with note conversion		-			(6,600	)
Derivative liability reduction associated with note conversion		-			(12,276	)
Officer debt and stock compensation forgiveness		-			(410,890	)
	$	-		$	(429,766	)
Supplemental Disclosure
Cash paid for interest	$	-		$	320

 

The accompanying notes are an integral part of these financial statements

 

F-5

JUBILANT FLAME INTERNATIONAL, LTD

NOTES TO FINANCIAL STATEMENTS

FOR THE THREE AND NINE MONTH PERIODS ENDED NOVEMBER 30, 2018 AND 2017

(UNAUDITED)

NOTE 1 – ORGANIZATION AND OPERATIONS

Jubilant Flame International, Ltd. (the "Company"), was formed on September 29, 2009 under the name Liberty Vision, Inc. On August 18, 2015, the Company changed its name to Jubilant Flame International, Ltd.

From the fourth quarter of the fiscal year ended February 28, 2018, the Company started to market and sell cosmetics products imported from Asia -Acropass Series products – in the United States market. The Company purchased the inventory from a related party company in China. The Company contracted with a third party to operate the online shopping platform and marketing campaign in the United States.

The Company has the right to develop and market medical products under a license from BioMark. The primary intended products include Bone-Induction Artificial Bone (“BIAB”) and Vacuum Sealing Drainage (“VSD”) but the Company currently does not have any plan to deploy such licenses and is focusing its operation on the Acropass products.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The Company’s financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

Interim Financial Information

Interim financial statements included herein have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") as promulgated in Item 210 of Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("US GAAP") have been condensed or omitted pursuant to such SEC rules and regulations. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of financial position as of November 30, 2018, results of operations, changes in stockholders' equity (deficit) and cash flows for the nine month periods ended November 30, 2018 and 2017, as applicable, have been made. The results for these interim periods are not necessarily indicative of the results for the entire year. The accompanying financial statements should be read in conjunction with the financial statements and the notes thereto included in the Company's Form 10-K.

Use of Estimates and Assumptions

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

The Company’s significant estimates include income tax provisions and valuation allowances of deferred tax assets; the fair value of financial instruments and the assumption that the company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.

F-6

Recent Accounting Pronouncements

Pronouncements Adopted in Fiscal 2018

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). This ASU represents a single comprehensive model to recognize revenue to depict the transfer of promised goods or services to a customer at an amount that reflects the consideration it expects to be entitled to in exchange for those goods or services. The Company has adopted this ASU since the interim period ending May 31, 2018, under the modified retrospective approach. The implementation of this ASU will result in no adjustment to retained earnings and current financial statements.

Net Loss Per Common Share

Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing net loss by the weighted average number of shares of common stock and potentially outstanding shares of common stock during each period.

NOTE 3 – GOING CONCERN

The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. As of November 30, 2018, the Company had current assets of $40,658, and current liabilities total $1,018,653 resulting in a working capital deficit of $977,995. The Company currently has small scale trading activities and has an accumulated deficit of $3,413,026 as of November 30, 2018. This raises substantial doubt about the Company's ability to continue as a going concern.

The Company may raise additional capital through the sale of its equity securities, through an offering of debt securities, or through borrowings from financial institutions or related parties. By doing so, the Company hopes to generate sufficient capital to execute its business plan in the cosmetics and medical sector on an ongoing basis. Management believes that actions presently being taken to obtain additional funding provide the opportunity for the Company to continue as a going concern. There is no guarantee the Company will be successful in achieving these objectives.

NOTE 4 – PREPAID EXPENSE

The Company is paying an annual fee for its OTC Markets service. The new service period is from December 1, 2018 to November 30, 2019. The service charge is recorded as a prepaid expense and amortized using straight line amortization over the service period. The prepaid expense balance is $12,000 as of November 30, 2018 compared to $7,500 as of February 28, 2018.

F-7

NOTE 5 – RELATED PARTY TRANSACTIONS

In support of the Company’s efforts and cash requirements, it must rely on advances from related parties until such time that the Company can support its operations or attains adequate financing through sales of its common stock or traditional debt financing. There is no formal written commitment for continued support by shareholders. The advances are considered temporary in nature and have not been formalized by a promissory note.

As of November 30, 2018, the Company had a $438,149 loan outstanding with its CEO, Ms. Yan Li. This compares with the outstanding balance of $390,828 to Ms. Yan Li at February 28, 2018. The loans are non-interest bearing, due upon demand and unsecured.

A related party is providing accounting service to the company at an estimated annual service fee of $20,000. From November 2017, the Company started to purchase cosmetic products from a related party controlled by our CEO. As of the nine-month period ended November 30, 2018, the Company incurred a total of $41,835 due to related party for inventory purchase and accrued service fee. This compares with a total of $12,842 due to related party for inventory purchase and accrued service fee at February 28, 2018.

NOTE 6 – ACCRUED OFFICER COMPENSATION AND STOCK COMPENSATION

On December 15, 2015, the Company entered into employment agreements with its president, Ms. Yan Li, and its secretary and treasurer, Mr. Robert Ireland.

On August 30, 2017, Mr. Robert Ireland resigned as Secretary/Treasurer of the company.

As of November 30, 2018, a total of $535,500 had been accrued as salary compensation payable compared to $460,125 at February 28, 2018 to the president only.

During the three months and nine months ended November 30, 2018, a total of $52,500 and $157,500 stock compensation had been recorded to the president respectively compared to $52,500 and $265,125 for the same periods in the prior year to the president and other directors.

NOTE 7 – STOCKHOLDERS EQUITY

At the nine month period ended November 30, 2018, a total of 75,000 Shares were issued to the president as stock compensation. Total value of $157,500 has been recorded for the stock compensation.

NOTE 8 – SUBSEQUENT EVENTS

None.

F-8

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with the financial statements and the notes to those statements included elsewhere in this Quarterly Report on Form 10-Q. This Quarterly Report on Form 10-Q contains certain statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Certain statements contained in the MD&A are forward-looking statements that involve risks and uncertainties. The forward-looking statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry, business and future financial results. Our actual results could differ materially from the results contemplated by these forward-looking statements due to a number of factors, including those discussed in other sections of this Quarterly Report on Form 10-Q.

Our Business

Jubilant Flame International, Ltd., (the "Company", "the "Registrant", "we", "us" or "our") was formed on September 29, 2009 under the name Liberty Vision, Inc. The Company provided web development and marketing services for clients. On December 5, 2012, the Company disposed of its subsidiary corporation to a shareholder for a nominal sum, as well as other management operations. On December 16, 2012, the Company changed its name to Jiu Feng Investment Hong Kong, Inc. On January 27, 2013, the Company announced the change of its ticker symbol from "LBYV" to "JFIL." On July 24, 2013, the Company changed its business sector to the medical sector. On August 18, 2015 the Company changed its name to Jubilant Flame International, Ltd.

From the fourth quarter of the fiscal year ended February 28, 2018, the Company started to market and sell cosmetics products imported from Asia -Acropass Series products – in the United States market. The Company purchased the inventory from a related party company in China. The Company contracted with a third party to operate the online shopping platform and marketing campaign in the United States.

The Company has the right to develop and market medical products under a license from BioMark. The primary intended products include Bone-Induction Artificial Bone (“BIAB”) and Vacuum Sealing Drainage (“VSD”) but the company currently does not have any plan to deploy such licenses and is focusing its operation on the Acropass products.

Results of Operations

Revenue

We recognized $24,099 sales revenue in the three months and $38,190 sales revenue in nine months ended November 30, 2018 respectively. There is no sales revenue in the three months and nine months ended November 30, 2017.

3

Operating Expenses

For the three months ended November 30,2018 compared to the three months ended November 30,2017

The major components of our operating expenses for the three months ended November 30, 2018 and 2017 are outlined in the table below:

	Three Months Ended		Three Months Ended
	Nov 30,		Nov 30,
	2018		2017
Officer compensation	$	77,625	$	77,625
Selling expense	$	10,897	$	-
Professional fee	$	10,367	$	88,379
Office expense	$	69	$	1,154
Web Amortization expense	$	-	$	2,083
OTC Filing fees	$	2,500	$	2,188
Total operating expenses	$	101,458	$	171,429

The $69,971 decrease in our operating costs for the three months ended November 30, 2018 compared to three months ended November 30, 2017, was mainly due to the $78,012 decrease in professional fee.

For the nine months ended November 30, 2018 compared to the nine months ended November 30, 2017

The major components of our operating expenses for the nine months ended November 30, 2018 and 2017 are outlined in the table below:

	Nine Months Ended		Nine Months Ended
	Nov 30,		Nov 30,
	2018		2017
Officer compensation	$	232,875	$	390,750
Transfer agent	$	5,000	$	4,867
Edgar filing fees	$	2,184	$	2,346
OTC service fees	$	7,500	$	7,188
Rent	$	-	$	6,000
Office expense	$	1,418	$	3,668
Web Amortization expense	$	3,473	$	6,250
Legal fees	$	2,739	$	3,760
Accounting fees	$	31,500	$	24,025
Selling and Marketing expense	$	24,395	$	77,497
Total operating expenses	$	311,084	$	526,351

The $215,267 decrease in our operating costs for the nine months ended November 30, 2018 compared to nine months ended November 30, 2017, was mainly due to the $157,875 decrease in officer compensation due to former treasurer resignation and $53,102 decrease in selling and marketing expense for new cosmetic product.

4

Other Expenses

Other expenses is zero for the three months ended November 30, 2018 and 2017 respectively.

Other expenses decreased to zero for the nine months ended November 30, 2018, from $7,678 for the nine months ended November 30, 2017. Other expenses consisted primarily of $4,238 decrease in debt discount amortization expense and $3,120 decrease in change in derivatives liability respectively.The change in other expense is mainly due to convertible note pay off in August 2017.

Net Loss

For the three months ended November 30, 2018, we recognized a net loss of $94,215 compared to the net loss of $171,429 for the corresponding period in 2017.

For the nine months ended November 30, 2018, we recognized a net loss of $297,236 compared to the net loss of $534,028 for the corresponding period in 2017.

Liquidity and Capital Resources

Working Capital

	November 30, 2018			February 28, 2018
Current Assets	$	40,658		$	22,063
Current Liabilities	$	1,018,653		$	863,795
Working Capital Deficit	$	(977,995	)	$	(841,732	)

As of November 30, 2018, the Company had $40,658 current assets, primarily comprising of inventory of $9,813, cash of $15,881 and prepaid expenses of $12,000, and current liabilities of $1,018,653, resulting in a working capital deficit of $977,995. The Company had limited profitable trading activities and has an accumulated deficit of $3,413,026 as at November 30, 2018. This raises substantial doubt about the Company's ability to continue as a going concern.

The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future.

Based on the Company’s current operating plan, the Company does not have sufficient cash and cash equivalents to fund its operations for at least the next twelve months. The Company will need to obtain additional financing to operate our business. The Company may raise additional capital through the sale of its equity securities, through an offering of debt securities, or through borrowings from financial institutions or related parties. By doing so, the Company hopes to generate sufficient capital to execute its business plan in the cosmetic and medical sector on an ongoing basis. Management believes that actions presently being taken to obtain additional funding provide the opportunity for the Company to continue as a going concern. There is no guarantee the Company will be successful in achieving these objectives.

5

Cash Flows from Operating Activities

Our net cash used in operating activities decreased by $93,582 in the nine months ended November 30, 2018 compared to the net cash used in operating activities in the nine months ended November 30, 2017, representing a decrease of 70%. The decrease in net cash used in operating activities was primarily the result of a $53,102 decrease in selling and marketing expense.

Cash Flows from Investing Activities

We did not generate or use any cash from investing activities during the three months ended November 30, 2018 or 2017.

Cash Flows from Financing Activities

Our cash provided by financing activities decreased from $136,798 for the nine months ended November 30, 2017 to $47,321 for the nine months ended November 30, 2018. In both periods, cash was provided by loans from related parties.

Future Financings

We anticipate that additional funding will be required in the form of equity financing from the sale of our common stock, through an offering of debt securities, or through borrowings from financial institutions or related parties. However, we cannot provide investors with any assurance that we will be able to raise sufficient funding from the sale of our common stock or through a loan from our directors to meet our obligations over the next twelve months.

Recent Accounting Pronouncements

Pronouncements Adopted in Fiscal 2018

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). This ASU represents a single comprehensive model to recognize revenue to depict the transfer of promised goods or services to a customer at an amount that reflects the consideration it expects to be entitled to in exchange for those goods or services. The Company adopts this ASU for the interim period ending May 31, 2018, under the modified retrospective approach. The implementation of this ASU will result in no adjustment to retained earnings and current financial statements.

Off Balance Sheet Arrangements

As of November 30, 2018, we did not have any off-balance-sheet arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we have conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as of the end of the period covered by this report. Based on this evaluation, our principal executive officer and principal financial officer concluded as of the evaluation date that our disclosure controls and procedures were not effective. We are presently examining changes to our procedures and policies to ensure a more timing reporting.

6

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

We were not subject to any legal proceedings during the nine months ended November 30, 2018, and currently we are not involved in any pending litigation or legal proceedings.

ITEM 1A. RISK FACTORS.

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. OTHER INFORMATION.

Not applicable.

7

ITEM 6. EXHIBITS

The following documents are filed as a part of this report:

EXHIBIT NUMBER	DESCRIPTION
31.1	Certification of the President and Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of the Chief Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of the President and Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS **	XBRL Instance Document
101.SCH **	XBRL Taxonomy Extension Schema Document
101.CAL **	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF **	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB **	XBRL Taxonomy Extension Label Linkbase Document
101.PRE **	XBRL Taxonomy Extension Presentation Linkbase Document

________

** XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

8

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	JUBILANT FLAME INTERNATIONAL LTD
Date: January 10, 2019	By:	/s/ Yan Li
		Yan Li
		President, Chief Executive Officer (Principal Executive Officer) and Director
Date: January 10, 2019	By:	/s/ Lei Wang
		Lei Wang
		Chief Financial Officer and Director

9